Search Results 161-170 of 968 for 🌟텔문의2만지급 토토오톡티비.COM 꽁머니사이트🌟

  1. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    The purpose of this study is to determine the safety profile of long-term vedolizumab IV treatment in pediatric participants with UC or CD. Participation ...

  2. A Study to Establish a Registry of Deep Brain Stimulation with the VERCISE™ System - Mayo Clinic

    The purpose of this study is to document characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Vercise™ System for ...

  3. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Ph 3 Trial of Blinatumomab vs Investigator's Choice of Chemotherapy in Patients with Relapsed or Refractory ALL - Mayo Clinic

    Adult subjects with R/R B-precursor ALL will be randomized in a 2:1 ratio to receive blinatumomab or treatment with investigator choice of 1 of 4 protocol ...

  5. MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) - Mayo Clinic

    The marker testing in this study will let doctors know if they can match patients with a treatment study (myeloMATCH clinical trial) that tests treatment for ...

  6. MBI Response toTam - Clinical Trials

    About this study. The study will examine whether changes in background parenchymal uptake (BPU) on molecular breast imaging (MBI) can be induced by ...

  7. Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - Mayo Clinic

    The goal of this study is to evaluate a new approach to immunotherapy in NHL by combining two antibodies, veltuzumab and epratuzumab. For treatment, epratuzumab ...

  8. A Study to Establish An Integrated Biomarker Panel for COVID-19 Infection Risk and Severity Prediction - Mayo Clinic

    Aim 2: Investigate if mutations or polymorphisms in genes (CXCR6, ACE2 and SLC6A20) linked to SARS-CoV-2 correlates with the three clinical patient outcome ...

  9. Analysis of Immunostaining during Mohs Micrographic Surgery to Improve Detection of Negative Surgical Margins in Patients with Squamous Cell Carcinoma and Chronic Lymphocytic Leukemia (CLL)/ Non-Hodgkins Lymphoma (NHL) - Mayo Clinic

    The goal of this study is to evaluate the use of immunostains during Mohs micrographic surgery (MMS) will improve detection of negative surgical margins in ...

  10. Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma - Mayo Clinic

    Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant ...